Patents by Inventor Ravi Jalluri

Ravi Jalluri has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TRIAZOLOTRIAZINES AS KINASE INHIBITORS
    Publication number: 20080039457
    Abstract: The present invention is directed to [1,2,4]triazolo[4,3-b][1,2,4]triazines, and pharmaceutical compositions thereof, which are inhibitors of kinases such as c-Met and are useful in the treatment of cancer and other diseases related to the dysregulation of kinase pathways.
    Type: Application
    Filed: August 6, 2007
    Publication date: February 14, 2008
    Applicant: INCYTE CORPORATION
    Inventors: Jincong Zhuo, Colin Zhang, Meizhong Xu, Ding-Quan Qian, Wenqing Yao, Ravi Jalluri
  • Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
    Publication number: 20070135461
    Abstract: The present invention provides heteroaryl substituted pyrrolo[2,3-b]pyridines and heteroaryl substituted pyrrolo[2,3-b]pyrimidines that modulate the activity of Janus kinases and are useful in the treatment of diseases related to activity of Janus kinases including, for example, immune-related diseases, skin disorders, myeloid proliferative disorders, cancer, and other diseases.
    Type: Application
    Filed: December 12, 2006
    Publication date: June 14, 2007
    Inventors: James Rodgers, Stacey Shepard, Thomas Maduskuie, Haisheng Wang, Nikoo Falahatpisheh, Maria Rafalski, Argyrios Arvanitis, Louis Storace, Ravi Jalluri, Jordan Fridman, Krishna Vaddi
  • Antibiotic cycloalkyltetrahydroquinoline derivatives
    Publication number: 20060287351
    Abstract: A method of treating a subject for a bacterial infection includes administering to a subject in need of treatment for a bacterial infection an effective amount of a compound represented by structural formula (I), or a pharmaceutically acceptable salt, solvate, or hydrate thereof. The variables in structural formula (I) are described herein.
    Type: Application
    Filed: August 11, 2004
    Publication date: December 21, 2006
    Inventors: Richard Labaudiniere, Yibin Xiang, Ravi Jalluri, Anthony Arvanites
  • Tetracyclic inhibitors of Janus kinases
    Publication number: 20060106020
    Abstract: The present invention provides compounds that modulate the activity of Janus kinases and are useful in the treatment of diseases related to activity of Janus kinases including, for example, immune-related diseases and cancer.
    Type: Application
    Filed: April 27, 2005
    Publication date: May 18, 2006
    Inventors: James Rodgers, Darius Robinson, Argrios Arvanitis, Thomas Maduskuie, Stacey Shepard, Louis Storace, Haisheng Wang, Maria Rafalski, Ravi Jalluri, Andrew Combs, Matthew Crawley